These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38902187)
1. Strategic vaccine stockpiles for regional epidemics of emerging viruses: A geospatial modeling framework. Carlson CJ; Garnier R; Tiu A; Luby SP; Bansal S Vaccine; 2024 Oct; 42(23):126051. PubMed ID: 38902187 [TBL] [Abstract][Full Text] [Related]
2. Projecting vaccine demand and impact for emerging zoonotic pathogens. Lerch A; Ten Bosch QA; L'Azou Jackson M; Bettis AA; Bernuzzi M; Murphy GAV; Tran QM; Huber JH; Siraj AS; Bron GM; Elliott M; Hartlage CS; Koh S; Strimbu K; Walters M; Perkins TA; Moore SM BMC Med; 2022 Jun; 20(1):202. PubMed ID: 35705986 [TBL] [Abstract][Full Text] [Related]
3. What is new in infectious diseases: Nipah virus, MERS-CoV and the Blueprint List of the World Health Organization. Rizzardini G; Saporito T; Visconti A Infez Med; 2018 Sep; 26(3):195-198. PubMed ID: 30246760 [TBL] [Abstract][Full Text] [Related]
5. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). Zumla A; Alagaili AN; Cotten M; Azhar EI BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081 [TBL] [Abstract][Full Text] [Related]
6. Advances in diagnostics, vaccines and therapeutics for Nipah virus. Thakur N; Bailey D Microbes Infect; 2019; 21(7):278-286. PubMed ID: 30817995 [TBL] [Abstract][Full Text] [Related]
8. CEPI: Driving Progress Toward Epidemic Preparedness and Response. Gouglas D; Christodoulou M; Plotkin SA; Hatchett R Epidemiol Rev; 2019 Jan; 41(1):28-33. PubMed ID: 31673694 [TBL] [Abstract][Full Text] [Related]
9. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus. Maslow JN Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484 [TBL] [Abstract][Full Text] [Related]
10. Vaccines to Emerging Viruses: Nipah and Hendra. Amaya M; Broder CC Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264 [TBL] [Abstract][Full Text] [Related]
11. Enhancing preparation for large Nipah outbreaks beyond Bangladesh: Preventing a tragedy like Ebola in West Africa. Donaldson H; Lucey D Int J Infect Dis; 2018 Jul; 72():69-72. PubMed ID: 29879523 [TBL] [Abstract][Full Text] [Related]
14. Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling study. Laydon DJ; Cauchemez S; Hinsley WR; Bhatt S; Ferguson NM Lancet Glob Health; 2023 May; 11(5):e759-e769. PubMed ID: 37061313 [TBL] [Abstract][Full Text] [Related]
15. Nipah virus: a narrative review of viral characteristics and epidemiological determinants. Sayed A; Bottu A; Qaisar M; Mane MP; Acharya Y Public Health; 2019 Aug; 173():97-104. PubMed ID: 31261032 [TBL] [Abstract][Full Text] [Related]
16. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology. Gilbert SC; Warimwe GM Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting. Abdirizak F; Lewis R; Chowell G Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665 [TBL] [Abstract][Full Text] [Related]